Search Results - "Unda, Santiago R."

Refine Results
  1. 1

    State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson's disease: What meta-analysis studies cannot tell us by Unda, Santiago R, Marciano, Sabina, Milner, Teresa A, Marongiu, Roberta

    Published in Frontiers in aging neuroscience (20-10-2022)
    “…The menopause is a midlife endocrinological process that greatly affects women's central nervous system functions. Over the last 2 decades numerous clinical…”
    Get full text
    Journal Article
  2. 2

    A novel severity score to predict inpatient mortality in COVID-19 patients by Altschul, David J., Unda, Santiago R., Benton, Joshua, de la Garza Ramos, Rafael, Cezayirli, Phillip, Mehler, Mark, Eskandar, Emad N.

    Published in Scientific reports (07-10-2020)
    “…COVID-19 is commonly mild and self-limiting, but in a considerable portion of patients the disease is severe and fatal. Determining which patients are at high…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Hemorrhagic presentations of COVID-19: Risk factors for mortality by Altschul, David J, Unda, Santiago R, de La Garza Ramos, Rafael, Zampolin, Richard, Benton, Joshua, Holland, Ryan, Fortunel, Adisson, Haranhalli, Neil

    Published in Clinical neurology and neurosurgery (01-11-2020)
    “…We aim to characterize the incidence, risk for mortality, and identify risk factors for mortality in patients presenting with hemorrhage and COVID-19. This…”
    Get full text
    Journal Article
  5. 5

    Peripheral Monocytosis at Admission to Predict Cerebral Infarct and Poor Functional Outcomes in Subarachnoid Hemorrhage Patients by Unda, Santiago R., Birnbaum, Jessie, Labagnara, Kevin, Wong, Megan, Vaishnav, Dhrumil P., Altschul, David J.

    Published in World neurosurgery (01-06-2020)
    “…Increasing evidence points monocytes' role to be larger than thought in developing cerebral infarction (CI) after subarachnoid hemorrhage (SAH). However, there…”
    Get full text
    Journal Article
  6. 6

    Beneficial effects of fish oil enriched in omega‐3 fatty acids on the development and maintenance of neuropathic pain by Unda, Santiago R., Villegas, Emilce A., Toledo, María Eugenia, Asis Onell, Gabriela, Laino, Carlos H.

    Published in Journal of pharmacy and pharmacology (01-03-2020)
    “…Objective The aim of this work was to assess the preventive effect of an eicosapentaenoic acid/docosahexaenoic acid‐concentrate fish oil on neuropathic pain…”
    Get full text
    Journal Article
  7. 7

    The effect of race on composite thrombotic events in patients with COVID-19 by Esenwa, Charles, Unda, Santiago R., Altschul, David J., Patel, Nikunj K., Malaviya, Avinash, Seiden, Johanna, Lendaris, Andrea, Moncrieffe, Khadean, Labovitz, Daniel L.

    Published in Thrombosis research (01-03-2021)
    “…COVID-19 associated coagulopathy and mortality related to thrombotic complications have been suggested as biological mediators in racial disparities related to…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Arterial Ischemic Stroke in Moyamoya Patients Who Underwent Vaginal Delivery and Cesarean Section by Antoniazzi, Aldana M., Unda, Santiago R., Khatri, Deepak, Holland, Ryan, De la Garza Ramos, Rafael, Haranhalli, Neil, Altschul, David J.

    Published in World neurosurgery (01-07-2022)
    “…Moyamoya disease (MMD) is characterized by stenosis, occlusion, and formation of aberrant collaterals of brain vessels. This derangement in the brain vessels…”
    Get full text
    Journal Article
  10. 10

    Western Moyamoya Phenotype: A Scoping Review by Miller, Raphael, Unda, Santiago R, Holland, Ryan, Altschul, David J

    Published in Curēus (Palo Alto, CA) (22-11-2021)
    “…Moyamoya, a rare angiographic finding, is characterized by chronic and progressive stenosis at the terminal end of the internal carotid artery, followed by…”
    Get full text
    Journal Article
  11. 11

    Thromboelastography (TEG) results are predictive of ischemic and hemorrhagic complications in patients with unruptured intracranial aneurysms treated with flow diversion by Javed, Kainaat, Unda, Santiago R, Holland, Ryan, Fortunel, Adisson, Fluss, Rose, Inocencio, Julio, Haranhalli, Neil, Altschul, David

    Published in Interventional neuroradiology (01-04-2022)
    “…Introduction Flow diversion is an effective treatment modality for intracranial aneurysms but is associated with ischemic and hemorrhagic complications…”
    Get full text
    Journal Article
  12. 12

    Classical Risk Factors for Ischemic Stroke are not Associated with Inpatient Post-Stroke Mortality in Sickle Cell Disease by Miller, Raphael, Klyde, Daniel M., Unda, Santiago R., Fluss, Rose, Altschul, David J.

    “…Sickle cell disease is a common haemoglobinopathy that significantly increases the risk of ischemic stroke. Because the risk factors for ischemic stroke onset…”
    Get full text
    Journal Article
  13. 13

    Younger age at intracranial aneurysms rupture among patients with opioid use disorders by Unda, Santiago R., Antoniazzi, Aldana M., de la Garza Ramos, Rafael, Osborn, Irene, Haranhalli, Neil, Altschul, David J.

    Published in Journal of clinical neuroscience (01-12-2021)
    “…[Display omitted] •Age at aneurysms rupture in patients with OUD was 12 years younger.•Aneurysm rupture is almost 17 years younger in OUD with additional drug…”
    Get full text
    Journal Article
  14. 14

    Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors by Unda, Santiago R., Antoniazzi, Aldana M., Miller, Raphael, Klyde, Daniel, Javed, Kainaat, Fluss, Rose, Holland, Ryan, De la Garza Ramos, Rafael, Haranhalli, Neil, Altschul, David J.

    “…Ischemic stroke and hemorrhagic stroke are the most common sequelae of the Moyamoya variants [Moyamoya disease (MMD) and syndrome (MMS)]. We sought to…”
    Get full text
    Journal Article
  15. 15

    Phosphoglycerate kinase is a central leverage point in Parkinson's disease-driven neuronal metabolic deficits by Kokotos, Alexandros C, Antoniazzi, Aldana M, Unda, Santiago R, Ko, Myung Soo, Park, Daehun, Eliezer, David, Kaplitt, Michael G, De Camilli, Pietro, Ryan, Timothy A

    Published in Science advances (23-08-2024)
    “…Although certain drivers of familial Parkinson's disease (PD) compromise mitochondrial integrity, whether metabolic deficits underly other idiopathic or…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Impact of hospital-acquired complications in long-term clinical outcomes after subarachnoid hemorrhage by Unda, Santiago R., Labagnara, Kevin, Birnbaum, Jessie, Wong, Megan, de Silva, Neranjan, Terala, Harshit, de la Garza Ramos, Rafael, Haranhalli, Neil, Altschul, David J.

    Published in Clinical neurology and neurosurgery (01-07-2020)
    “…Patients with subarachnoid hemorrhage (SAH) usually have prolonged hospitalizations due to the need to closely monitor their neurological status. Therefore,…”
    Get full text
    Journal Article
  18. 18

    Analyzing the Effects of Demographic Differences on Patient Outcomes Following Non-pyogenic Intracranial Venous Thrombosis by Labagnara, Kevin F, Birnbaum, Jessie, Unda, Santiago R, Altschul, David J

    Published in Curēus (Palo Alto, CA) (19-11-2021)
    “…To investigate the effect of racial and demographic differences on the short-term outcome of patients following a non-pyogenic cerebral venous thrombosis. Data…”
    Get full text
    Journal Article
  19. 19

    Predictors of mortality for patients with COVID-19 and large vessel occlusion by Altschul, David J, Esenwa, Charles, Haranhalli, Neil, Unda, Santiago R, de La Garza Ramos, Rafael, Dardick, Joseph, Fernandez-Torres, Jenelys, Toma, Aureliana, Labovitz, Daniel, Cheng, Natalie, Lee, Seon-Kyu, Brook, Allan, Zampolin, Richard

    Published in Interventional neuroradiology (01-10-2020)
    “…Background This study evaluates the mortality risk of patients with emergent large vessel occlusion (ELVO) and COVID-19 during the pandemic. Methods We…”
    Get full text
    Journal Article
  20. 20